Healthcare entity
market-trends is the sole category represented across all 1 tracked stories. Dr. Reddy's Laboratories is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 8, the average consequence score sits above the same-window beat average of 6.6.
Last mentioned: Mar 25, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Dr. Reddy's Laboratories is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 8, the average consequence score sits above the same-window beat average of 6.6. Source depth averages 3 original sources per story, versus 3.3 across the same-window beat baseline. We currently track 1 Healthcare story that mention India Pharmaceutical Sector, all published on March 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 26 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering India Pharmaceutical Sector. Shared-story counts are live from our verified record — not editorial picks.
Indian pharmaceutical manufacturers have begun a massive rollout of affordable versions of popular GLP-1 weight-loss medications. This move targets global supply gaps and threatens the pricing dominance of Western pharmaceutical giants in emerging markets.
Source: argentinastar.com · japanherald.com
India Pharmaceutical Sector is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
